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Summary
 
The early growth response (Egr)-1 is a zinc finger–containing transcription factor belonging to
the immediate–early genes. Its expression in CD4/CD8 double negative (DN) immature thy-
mocytes suggests that Egr-1 expression may be involved in early thymocyte development. In
transgenic mice overexpressing Egr-1 in a recombinase-activating gene–deficient background,
thymocytes bypassed the block at the CD25
 
1
 
CD44
 
2
 
 DN stage and matured to the immature
CD8 single-positive (ISP) cell stage, but not further to the CD4/CD8 double-positive (DP)
cell stage. When these mice were irradiated, thymocytes did develop to the DP stage, suggest-
ing transcriptional induction of additional genes by irradiation that are required to promote
thymocyte development from the ISP to the DP stage. These results provide genetic evidence
for two distinct steps during early thymocyte development from the CD25
 
1
 
CD44
 
2
 
 DN to the
DP stage. The first step, from the CD25
 
1
 
CD44
 
2
 
 DN to the ISP stage, can be entirely pro-
moted by overexpression of Egr-1.
 
I
 
ntrathymic 
 
a
 
/
 
b
 
T cell development can be grossly sepa-
rated into three phases based on the configuration of
TCR genes and the expression of cell-surface markers in-
cluding the CD4 and CD8 coreceptors. In the earliest
phase, thymocytes are characterized by TCR loci in germ-
line configuration and thus, no surface expression of any
TCR protein. The most immature cells identified in this
first phase are present in small numbers and express c-kit
and low levels of CD4 (1). Thymocyte maturation is ac-
companied by loss of CD4 and onset of CD44 expression,
immediately followed by CD25 expression (the CD25
 
1
 
CD44
 
1
 
CD4/CD8 double-negative [DN]
 
1
 
 stage) and finally, down-
regulation of CD44 and c-kit expression (2). This final mat-
uration stage of the first phase is defined as the CD25
 
1
 
CD44
 
2
 
DN stage, during which rearrangement of TCR-
 
b
 
 gene
begins and functional TCR-
 
b
 
 chains are expressed on the
cell surface associated with the pre–TCR-
 
a
 
 chain (3) as a
pre-TCR complex. Several cytokine and cytokine recep-
tor–deficient mice have implied that this first phase of thy-
mocyte development appears entirely dependent on growth
factors. IL-7/IL-7 receptor (4, 5), IL-2 receptor–
 
g
 
 (com-
mon 
 
g
 
 chain) (6–8), and c-kit (9) –deficient mice revealed a
mild, but not complete, block of early thymocyte develop-
ment. More recently, Rodewald et al. reported a complete
block before TCR-
 
b
 
 gene rearrangement in c-kit/common
 
g
 
 chain double mutant mice (10).
The second phase of thymocyte development begins
with expression of the pre-TCR complex. Several mutant
mice have revealed that expression of the pre-TCR com-
plex plays a key role during subsequent development. Re-
combinase-activating gene deficient (RAG
 
2
 
/
 
2
 
) mice in which
TCR-
 
b
 
 genes cannot be rearranged and hence no pre-
TCR complex is expressed on the cell surface, have complete
block of thymocyte development at the CD25
 
1
 
CD44
 
2
 
 stage
(11, 12). In addition, TCR-
 
b
 
2
 
/
 
2
 
 (13) and pre–TCR-
 
a
 
2
 
/
 
2
 
mice (3) show greatly reduced numbers of CD4
 
1
 
CD8
 
1
 
double-positive (DP) cells. This first checkpoint regulated
by the pre-TCR complex is termed 
 
b
 
 selection (14).
When the pre-TCR complex is expressed and its signaling
is initiated, thymocytes lose CD25 expression and, in mice,
most start to express CD8 molecules. After this immature
CD8 single-positive (ISP) stage (15–18), thymocytes begin
to express CD4 molecules and become CD4/CD8 DP
cells. During this process, TCR-
 
a
 
 genes undergo rear-
rangement, and the TCR
 
a
 
/TCR
 
b
 
 (TCR-
 
a
 
/
 
b
 
) complex
is expressed on the cell surface. The second checkpoint for
the final steps of thymocyte maturation is positive/negative
selection, which depends on the interaction between TCR-
 
1
 
Abbreviations used in this paper:
 
 DN, double negative; DP, double-posi-
tive; Egr, early growth response; hGH, human growth hormone; HSA,
heat-stable antigen; ISP, immature CD8 single-positive; NL, negative lit-
termates; RAG, recombinase-activating gene; RT-PCR, reverse tran-
scriptase PCR; Tg, transgenic.
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Egr-1–induced Thymocyte Development in RAG-2
 
2/2
 
 Mice
 
a
 
/
 
b
 
 and MHC complexes, but is also influenced by the
CD4 and CD8 coreceptors. Cells surviving selection can
achieve development to mature to CD4 or CD8 single-
positive cells, exit the thymus, and enter the periphery. Al-
though these developmental processes are well described
phenotypically, the molecular mechanisms involved in de-
velopmental control is still unclear.
The molecular events during the second phase of thy-
mocyte development between the two checkpoints for 
 
b
 
selection and TCR-
 
a
 
/
 
b
 
 selection are elusive because a
possible ligand for the pre-TCR complex, which plays a key
role in this period, has not been identified. Although a re-
cent report suggested CD81, a transmembrane 4 superfam-
ily protein, as a potential candidate for the pre-TCR ligand
(19), this is unlikely because CD81-deficient mice (20, 21)
have normal thymocyte development. Alternatively, this is-
sue has been studied intensively using RAG
 
2
 
/
 
2
 
 mice. Sev-
eral experimental manipulations of the mutant mice either by
irradiation (22, 23), CD3 ligation (24, 25) as well as intro-
duction of activated lck (26) or activated ras (27) transgenes
effectively bypass 
 
b
 
 selection and promote thymocyte devel-
opment to the DP stage in the absence of pre-TCR expres-
sion. All of these stimuli somehow compensate for pre-TCR–
mediated signaling. Because all of these manipulations can
activate the Ras protein (28), a ras-related pathway could
play an important role in 
 
b
 
 selection as well as in further
developmental progression to the DP stage. Downstream of
Ras, however, multiple pathways may be involved which have
not yet been dissected. Intracellular signals during this rapid
developmental process must be differentially controlled, and
rapidly responding transcriptional regulators able to elicit a
cascade of changes in gene expression should be necessary.
Immediate–early genes, expression of which is rapidly
induced after cell-surface receptor ligation without de novo
protein synthesis (29), are strong candidates for such rapid
response mediators. Many of these genes encode transcrip-
tion factors such as c-jun and c-fos, as well as the zinc fin-
ger–containing early growth response (Egr) family mem-
bers (30, 31). Of these Egr family members, early growth
response (Egr)-1, also known as krox-24, NGFI-A, zif-268,
and Tis-8, has been studied most intensively for its involve-
ment in T cell function and activation, because of its rapid
expression after TCR ligation (32–35). However, Egr-1 is
expressed not only in mature T cells, but also in thymo-
cytes. Shao et al. recently reported the expression of Egr-1 in
DN immature thymocytes, suggesting a potential involvement
in 
 
b
 
 selection (36). Nevertheless, very little functional infor-
mation is available concerning the possible involvement of
Egr-1 in thymocyte development.
In this report, a potential role for Egr-1 expression in
thymocyte development is described. First, endogenous Egr-1
expression in DN thymocytes from wild-type (C57Bl/6)
mice was dissected in detail. Second, by generating RAG-
2
 
2
 
/
 
2
 
 transgenic mice that overexpress Egr-1 in immature
thymocytes, the functional effects of Egr-1 expression on 
 
b
 
selection as well as further development of thymocytes
were evaluated.
 
Materials and Methods
 
Mice.
 
All mice used here were maintained in the specific
pathogen-free facility of the Basel Institute for Immunology.
Matched sets of littermates with transgene-positive and -negative
genotypes were used in all experiments.
 
Generation of Transgenic Mice.
 
A 
 
l 
 
clone containing a 16-kb
genomic DNA fragment including the whole Egr-1 sequence
(clone GE-1) was isolated by screening a genomic DNA library
from 129/SVJ mice (Stratagene Corp., La Jolla, CA) with an Egr-1
cDNA fragment cloned into the EcoRI site of pBluescript (
 
32
 
P-
labeled Egr-1 cDNA fragment: positions 121–1,970, numbering
according to ref. 33). A 2.3-kb ApaI–BglII fragment was sub-
cloned and then the 5
 
9
 
 end ApaI site was modified to a BamHI
site by T4 DNA polymerase and a BamHI linker. The BamHI–
BglII fragment was cloned into the BamHI site of the plck-human
growth hormone (hGH) expression vector (37). The complete plas-
mid (plck-Egr) was digested with NotI and the transgene fragment
no longer containing vector sequence was purified by Geneclean II
(BIO101, Vista, CA). DNA was microinjected into fertilized eggs
of C57Bl/6 
 
3
 
 DBA
 
2
 
 F
 
2
 
 mice (BDF
 
2
 
). Resulting founders were
screened for transgene by Southern blot and PCR. Three inde-
pendent founders carried the transgene. All three mice were
backcrossed within RAG-2
 
2
 
/
 
2
 
 background.
 
Northern Blot Analysis.
 
Total RNA was isolated from thymus
using RNAzolB solution (Tel-Test. Inc., Friendswood, TX) ei-
ther from transgenic mice or negative littermates with a RAG-
2
 
1
 
/
 
2
 
 background. 15 
 
m
 
g total RNA was denatured, electro-
phoresed on 1% agarose gel, blotted on nylon membrane, and
then hybridized with 
 
32
 
P-labeled Egr-1 cDNA fragment.
 
Reverse Transcriptase PCR.
 
Thymocytes were stained for
CD4, CD8, CD25, and CD44, and then appropriate cell popula-
tions were sorted by FACstar
 
Ò
 
 (Becton Dickinson, Mountain
View, CA). From 50,000 cells of each population, total RNA
was isolated by RNAzolB solution (Tel-Test, Inc.), and cDNA
was synthesized by reverse transcriptase with random-hexamer
primers. PCR was performed with titrated amounts of this
cDNA as template, using a set of primers: 5
 
9
 
-TGCTCCTG-
GCTTTTGGCCTGCTCTG (positions 26–50 of the hGH
cDNA sequence, from ATG, the start codon) and 5
 
9
 
-GTTGT-
GTGAGTTTGTGTCGAACTT (positions 534–511) for trans-
gene expression, 5
 
9
 
-GCAGATCTCTGACCCGTTCGG (posi-
tions 300–320 of the mouse Egr-1 cDNA, according to ref. 33)
and 5
 
9
 
-CCGAGTCGTTTGGCTGGGATA (positions 630–610)
for Egr-1 expression, 5
 
9
 
-ATGGATGACGATATCGCTGCG (po-
sitions 80–101, regarding ref. 38), and 5
 
9
 
-CATGTTCAATGG-
GGTACTTCA (positions 300–280) for 
 
b
 
 actin expression. PCR
reactions were performed as described; 10% of each reaction was
analyzed on a Southern blot with either an hGH, Egr-1, or 
 
b
 
 actin
cDNA probe.
 
Serological Reagents and Flow Cytometry.
 
Reagents used for
staining T cells and subsets thereof were as described (39–41, and
references therein). Thymus, lymph node, and spleen cells were
stained with saturating levels of mAbs and analyzed using a FAC-
Scan
 
Ò
 
 cytometer.
 
Cell Cycling Analysis.
 
100,000 ISP thymocytes were sorted and
fixed in 70% ethanol at 4
 
8
 
C overnight. Cells were collected by
centrifugation and then resuspended in 500 
 
m
 
l of RNase A (0.5
mg/ml in 0.1 M Tris, pH 7.5, 0.1 M NaCl; Sigma Chemical Co.,
St. Louis, MO) and incubated for 30 min at 37
 
8
 
C. 500 
 
m
 
l of pep-
sin (1 mg/ml in 0.4% HCl; Sigma Chemical Co.) was added,
mixed well, and incubated for 15 min at 37
 
8
 
C. 1 ml of ethidium
bromide (0.02 mg/ml in 0.2 M Tris, pH 8.5, 0.5% BSA) was 
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then added, mixed well, and incubated for another 15 min at
room temperature with protection from light. After the incuba-
tion, the sample was analyzed directly using a FACScan
 
Ò
 
 with the
double discriminating module.
 
TCR Rearrangement Assay.
 
100,000 thymocytes were sorted
from various populations. Cells were digested in cell lysis buffer;
1
 
3
 
 SSC, 10 mM Tris, pH 7.4, 1 mM EDTA, 0.5% SDS contain-
ing protenase K (Sigma Chemical Co.) at 0.1 mg/ml in a 55
 
8
 
C
water bath with vigorous shaking for 2 h. Samples were treated
with phenol/chloroform solution once and then ethanol precipi-
tated. DNA corresponding to 5,000 cells was used as template for
PCR reactions. PCR reactions were performed for 25, 30, 35,
and 40 cycles under the following conditions: 94
 
8
 
C for 1 min,
60
 
8
 
C for 1.5 min, 72
 
8
 
C for 1.5 min in a total 20 
 
m
 
l of volume.
Primers used for V
 
a
 
 rearrangement detection were 5
 
9
 
-CAG-
AAGGTGCAGCAGAGCCCAGAA (V
 
a
 
5H), 5
 
9
 
-ACTGTC-
TCTGAAGGAGCCTCTCTG (V
 
a
 
2C), 5
 
9
 
-ACCCAGACAGAA-
GGCCTGGTCACT (V
 
a
 
F3), and 5
 
9
 
-GACCCTATTACT-
CACATACTTGGCTTG (V
 
a
 
TT11); and for V
 
b
 
 rearrangement
detection were, 5
 
9
 
-CCTGATTGGTCAGGAAGGGC (V
 
b
 
6),
5
 
9
 
-TCCCTGATGGGTAGAAGGCC (Vb8), and 59-TAACAC-
GAGGAGCCGAGTGC (Jb2.5), as described (42). 10% of each
reaction was analyzed on a Southern blot with a 32P-labeled inter-
nal oligo as a probe, for Va, 59-GAAAGCAGAGTCCCAAT-
TCCAAAG, for Vb, 59-CTGGCCCAAAGTACTGGGTG. As
a control, the b actin gene was amplified from each template us-
ing primers 59-TTGAGACCTTCAACACCCCAG (positions
450–471, according to ref. 37) and 59-CGAAGTCTAGAG-
CAACATAGC (positions 750–730), and then hybridized with a
b actin cDNA fragment.
Results
Endogenous Egr-1 Expression in DN Thymocytes of Wild-
type Mice. Shao et al. recently described Egr-1 expression
in DN thymocytes of mice using intracellular fluorocytom-
etry and suggested the possible involvement of Egr-1 expres-
sion during b selection in immature thymocytes (36). Be-
cause the pre-TCR–expressing population in DN thymocytes
can be distinguished by CD25/CD44 expression, endoge-
nous Egr-1 expression was dissected in DN thymocytes from
wild-type C57Bl/6 (B6) mice by semiquantitative reverse
transcriptase PCR (RT-PCR), using sorted CD251CD442
cells that precede pre-TCR expression, and CD252CD442
cells that express the pre-TCR complex. As shown in Fig.
1, much higher endogenous Egr-1 expression was detected
in CD252CD442 cells than in CD251CD442 cells. Egr-1
was expressed at even higher levels in DP cells than in CD252
CD442 DN cells, consistent with the recent report (36).
Generation of Transgenic Mice Overexpressing Egr-1 in Thy-
mocytes with a RAG-22/2 Background. Pre-TCR–mediated
signals are necessary to promote development from the
CD251CD442 to the CD252CD442 stage as revealed in
several mutant mice. For instance, in RAG-22/2 mice
lacking pre-TCR expression, thymocyte development is
blocked at the CD251CD442 stage (12). The increased ex-
pression of Egr-1 seen in CD252CD442 DN thymocytes
(Fig. 1) might reflect induction of Egr-1 expression by pre-
TCR engagement, which may help to promote develop-
ment of DN thymocytes from the CD251CD442 to the
CD252CD442 stage. To test this hypothesis, transgenic
mice designed to overexpress Egr-1 in immature thy-
mocytes were generated and bred to RAG-22/2 mice (12).
The Lck proximal promoter was used to limit transgene
expression primarily to immature thymocytes (37, 43). A
mouse genomic DNA fragment of the Egr-1 gene, includ-
ing coding exons and intron 1 but no 39 noncoding se-
quence was used to insure efficient and stable expression of
transcripts (44, 45). Three independent lines of transgenic
founder mice were obtained. Phenotypes of these original
transgenic mice will be detailed elsewhere (Miyazaki, T.,
and U. Müller, manuscript in preparation). All three lines
were backcrossed to RAG-22/2 mice. All progeny carrying
the transgene were of normal size and appeared healthy. As
observed for many other transgenes driven by this pro-
moter (43), transgene expression in the thymus was de-
tected at levels far exceeding the endogenous Egr-1 when
analyzed by Northern blotting using thymic RNA from
transgenic and negative littermate mice, both of which had
a RAG-21/2 background (data not shown). All three lines
showed essentially the same expression levels.
Thymocyte Development. The thymi of Egr-1 transgenic
mice with a RAG-22/2 background (Egr-1 Tg-RAG2)
were significantly larger than those of RAG-22/2 negative
littermates (NL-RAG2). The absolute number of thy-
mocytes was 3.5 (6 0.5) 3 106 in Egr-1 Tg-RAG2 (n 5
10), compared to 1.2 (6 0.3) 3 106 in NL-RAG2 (n 5
10). Typical staining profiles of thymocytes are presented in
Fig. 2 a. The most impressive aberration in the transgenic
thymi was the presence of a large population (30%) of
CD42CD81 cells. These CD81 cells are CD25-negative (Fig.
2 b) and display lower heat-stable antigen (HSA) levels than
those on DN cells, but higher levels than those on DP cells
(Fig. 2 c), indicating that they are ISP transitional stage thy-
mocytes (15–18). Consistently, size profiles of total thymocytes
show that smaller cells appeared (Fig. 2 d) and a significant
population (18%) of CD252CD442 DN cells was detected
in Egr-1 Tg-RAG2 thymi (Fig. 2 e). Thus, overexpression
of Egr-1 promoted thymocyte development from the DN
to the ISP stage, overcoming the b block in the RAG-22/2
background. In accordance with this, small numbers of ISP
cells appeared to express CD4 also, falling into the CD4/
CD8-DP quadrant (Fig. 2 a). These cells form, however, a
very small (2%), indistinct population, possibly representing
the intermediate stage cells between the ISP and the DP.
Neither mature single-positive thymocytes nor peripheral
Figure 1. Increased endoge-
nous Egr-1 expression in
CD252CD442 DN thymocytes
of wild-type (C57Bl/6) mice.
CD251CD442 DN, CD252
CD442 DN, and DP thymocytes
were sorted from C57Bl/6 (B6)
mice, total RNA was isolated,
and the expression of Egr-1 gene was assessed by semiquantitative RT-
PCR. The amount of template cDNA for PCR corresponds to 5 3 104,
5 3 103, or 103 cells from the left lane to the right in each type of cell.880 Egr-1–induced Thymocyte Development in RAG-22/2 Mice
T cells were detected in either Egr-1 Tg-RAG2 or NL-
RAG2 mice. ISP cells isolated from Egr-1 Tg-RAG2
could not develop to the DP stage spontaneously in in vitro
culture for 12–24 h (data presented in following section as
Fig. 3 d).
DN and ISP cells from transgenic thymi were sorted,
and transgene expression in each population was confirmed
by RT-PCR. To avoid amplification of endogenous Egr-1
transcripts, a set of primers specific for the hGH gene se-
quence present in transgene transcripts was used. Transgene
expression was detected in either CD251CD442, CD252
CD442, or ISP cells (data not shown).
Irradiation-induced DP Cell Development in Egr-1 Tg Mice
with a RAG-22/2 Background. As discussed above, once
the  b block is bypassed in a RAG2/2 thymus, either by ir-
radiation, CD3-ligation, or by expression of activated lck
or ras transgenes, thymocytes do mature to the DP stage,
whereas in Egr-1 Tg-RAG2 mice, the vast majority of
thymocytes develop to the ISP stage, but not to the DP
stage. Two potential explanations can be considered for
Figure 2. Development of ISP cells induced by Egr-1 expression in
RAG-22/2 mice. Thymocyte suspensions from 6–8-wk-old transgenic
mice or negative littermates, both with a RAG-22/2 background, were
stained and analyzed by fluorocytometry. (a) CD4/CD8 profiles. Num-
bers indicate relative percentages of positive cells within a quadrant. The
average of the total thymocyte numbers of 10 of each type of mice are in-
dicated above the profiles. (b) CD25 expression of total thymocytes from
transgenic or negative littermates (top) or CD81 cells from transgenic
mice. (c) HSA histograms. (d) Side scatter (SSC)/forward scatter (FSC)
profiles indicating cell size. Only living cells were gated. (e) CD25/CD44
profiles of DN cells. Thymocytes were stained with anti-CD25–Tricolor,
anti-CD44–FITC, anti-CD4–PE, and anti-CD8–PE. PE-negative cells
(CD4/CD8 DN cells) were gated and analyzed for CD25/CD44 expres-
sion. Numbers indicate relative percentages of positive cells within a
quadrant.881 Miyazaki
this difference. First, overexpression of Egr-1 is sufficient to
drive development of DN thymocytes to the ISP stage, but
other gene(s) might be required to promote ISP cells to the
DP stage. Second, overexpression of Egr-1 at ISP stage
might interfere with further development of ISP cells to-
wards the DP stage.
To investigate this question, both Egr-1 Tg-RAG2 and
NL-RAG2 mice were sublethally irradiated (600 rads) and
their thymi were examined. As observed previously (22),
the thymic cellularity in both Tg and negative littermates
was strikingly decreased 2–3 d after irradiation. Most of the
thymocytes were dead when examined by trypan blue ex-
clusion (data not shown), and very few living ISP cells
were detected in irradiated Tg thymi by fluorocytometric
analysis (data not shown). 4 wk after irradiation, however,
thymi were significantly enlarged as compared to nonirra-
diated thymi both in Tg and negative littermates, and the
absolute numbers of thymocytes were 1.8 (6 0.3) 3 107 in
Tg versus 1.0 (6 0.2) 3 107 in negative littermates (n 5 7
each). As shown in Fig. 3 a, in both types of mice, an obvi-
ous DP population appeared which was 1.2 (6 0.2) 3 107
cells in Tg and 0.8 (6 0.1) 3 107 cells in negative litter-
mates. Large numbers of total thymocytes both in Tg and
negative littermates did not express CD25 as shown in Fig.
3 b. These results indicate that overexpression of Egr-1
does not block thymocyte development from the ISP to
the DP stage and, therefore, perhaps additional gene(s) in-
duced by irradiation are required to drive ISP cells to the
DP stage.
In the thymus of Egr-1 Tg- RAG2 4-wk after irradia-
tion, a substantial population (20%) of CD42/lowCD81 cells
was detected. This population differs from the ISP cells in
nonirradiated Egr-1 Tg- RAG2 thymi, since the ISP cells
disappeared soon after irradiation. However, these cells are
apparently repopulated ISP and ISP/DP intermediate stage
cells because their peanut agglutinin–binding capacity
which is reduced as thymocytes mature, is even higher than
that of DP cells (Fig. 3 c), indicating that these CD42/low
CD81 cells are more immature than DP cells. This is also
supported by the observation that these CD42/lowCD81
cells bear higher levels of HSA than do DP cells, but lower
levels than do DN cells (data not shown). In addition, ISP
cells isolated from irradiated Egr-1 Tg-RAG2 mice sponta-
neously mature to the DP stage in 12–24 h of culture (Fig.
3 d), indicating these immature cells have the potential to
mature into DP cells, in sharp contrast to ISP cells from
nonirradiated Egr-1 Tg-RAG2 mice which do not de-
velop to the DP cell stage in identical culture conditions
(Fig. 3 d).
In both types of mice, no mature CD41 or CD81 cells
were detected, which is consistent with previous reports
regarding irradiated RAG2/2 mice (22, 23). TCR Va and
Vb rearrangements were examined in each sorted popula-
Figure 3. Development of DP cells induced by irradiation. Both trans-
genic mice and negative littermates with a RAG-22/2 background were
sublethaly irradiated (600 rads). 4 wk after irradiation, their thymocyte
suspensions were stained and analyzed by a fluorocytometer. (a) CD4/
CD8 profiles. Numbers indicate relative percentages of positive cells
within a quadrant. The average of the total thymocyte numbers of seven
of each type of mice are indicated above the profiles. (b) CD25 expression
on total thymocytes. (c) Peanut-agglutinin binding capacity of each sub-
population. (d) In vitro culture of ISP cells. 50,000 ISP cells were sorted
from irradiated or nonirradiated transgeic mice with a RAG-22/2 back-
ground and cultured in 200 ml of complete culture medium for 12–24 h.
After the culture period, cells were stained for CD4 and CD8, and ana-
lyzed by fluorocytometer. This experiment was repeated three times and
the results were reproducible. A representative result is shown.882 Egr-1–induced Thymocyte Development in RAG-22/2 Mice
tion and, as expected (22, 23), no rearrangement could be
detected in any thymocyte population, either from irradi-
ated transgenic or negative littermates with a RAG-22/2
background (data not shown).
Cell Cycling of ISP Cells in Egr-1 Tg with a RAG1 Back-
ground. Seeing a significant population of ISP (and ISP/
DP intermediate) cells in Egr-1 Tg-RAG2 mice even after
irradiation, which have the potential to further develop to
the DP stage, I wondered if overexpression of Egr-1 might
lead the ISP cells to be hyperproliferative, resulting in en-
largement of this population in the profiles. To asses this
question, the cell cycle of ISP cells was determined. To
compare the fraction of cycling cells between Egr-1 over-
expressing ISP and normal ISP cells, RAG1 background
Tg (Egr-1 Tg-RAG1) and NL-RAG1 mice were used. In
RAG1 background animals, ISP cells can be distinguished
as CD81 TCRlow. These cells were sorted from Egr-1 Tg-
RAG1 and NL-RAG1 mice, and their cell cycling condi-
tion was examined by DNA content .
As shown in Fig. 4, essentially the same percentage of
ISP cells from transgenic and negative littermate mice were
in S or G2/M phase, indicating that cell cycling was not al-
tered by Egr-1 overexpression.
More Efficient Maturation from the DN to the ISP Stage in Ir-
radiated Egr-1 Tg Mice. An alternative explanation for the
large population of ISP (and ISP/DP intermediate) cells in
irradiated Egr-1 Tg-RAG2 thymi is that the high level of
Egr-1 expression might boost the thymocyte maturation
from the DN to the ISP stage. This question was assessed
by comparing the CD25/CD44 profiles of DN cells in
both types of mice 4 wk after irradiation. Fig. 5 shows his-
tograms of CD25 expression in CD442 DN thymocytes.
In irradiated NL-RAG2 thymi, two clear populations
(CD252 and CD251 ) could be identified and seven (6
2.0; n 5 8) percent of CD442 DN cells exhibited the
CD252 phenotype. In irradiated Egr-1 Tg-RAG2 thymi,
however, CD252 and CD251 populations were not clearly
separated, and a large population of intermediate (CD25low
CD442) cells bearing broadly differing levels of CD25
were observed. Using the same gate as for the negative lit-
termate cells, CD252 cells were 22 (6 1.6; n 5 8) percent
of CD442 DN cells. In addition, the relative peak intensity
of the CD251 population was 1.7 times higher in negative
littermates than in Tg mice, indicating that many of the
CD251CD442 cells had shifted to the CD252CD442
stage. This shift was detected even in nonirradiated Egr-1
Tg-RAG2 DN cells (see Fig. 2 e). These results suggest
that the maturation may be boosted in Egr-1 Tg DN thy-
mocytes. An increase in the number of CD42CD8low in ir-
radiated Tg thymi (6 [6 0.8] 3 105 in Tg versus 1.7 [6
0.5] 3 104 in negative littermate thymus [n 5 8 each]),
might also reflect the boost also during maturation from the
CD252CD442 DN to the ISP cell stage.
Figure 4. Normal cell cycling in ISP cells of transgenic mice. ISP
(CD81TCRlow) thymocytes from transgenic mice or negative littermates
with a RAG-21/1 background were sorted and their DNA content was
determined. The high peaks at z75 of relative intensity represent the G1
phase DNA and the other smear part at z200 represents the S or G2/M
phase DNA. The amount of S or G2/M phase DNA was essentially same
in transgenic mice and negative littermate controls.
Figure 5. More CD252/lowCD442 DN cells in irradiated transgenic
thymus than in irradiated negative littermate thymus. Thymocyte suspen-
sions from either irradiated transgenic or irradiated negative littermate
mice 4 wk after irradiation were stained for CD4, CD8, CD25, and
CD44 and analyzed by fluorocytometry. CD442 DN cells were gated and
their CD25 expression is presented. Percentages of the CD25-negative
population (the gate for which was created using the negative littermate’s
histogram as a standard) are indicated.883 Miyazaki
Discussion
Egr-1 Overexpression Is Sufficient to Promote Development of
CD251CD442 DN Cells to the CD252CD442 DN and
Further to the ISP Stage. As previously discussed, pre-
TCR independent development of thymocytes in RAG2/2
mice has been achieved by various experimental manipula-
tions, including irradiation, CD3 ligation, and introduction
of several transgenes. These stimuli are thought to compen-
sate for signaling through the pre-TCR complex, though
the precise molecular mechanisms are unknown. Because
all of these manipulations can activate Ras (28), activation
events downstream of the Ras pathway might be strong
candidates for key players in promoting thymocyte devel-
opment beyond b selection. We are, however, entirely ig-
norant of the gene regulation/transcription involved in this
maturation control. In this report, an immediate–early
gene, Egr-1, is presented as a primary transcription factor,
overexpression of which does initiate thymocyte develop-
ment in RAG-22/2 mice.
The initial observation that endogenous Egr-1 expres-
sion is far upregulated in CD252CD442 DN cells in com-
parison to the immediately preceding CD251CD442 DN
population, suggested that Egr-1 might be induced after li-
gation of the pre-TCR complex and a set of genes which
are transcriptionally regulated by Egr-1 could possibly play
key roles in promoting CD251CD442 DN cells to develop
to the CD252CD442 stage. This idea was well supported
by transgenic mice overexpressing Egr-1 with a RAG-22/2
background in which CD251CD442 DN cells achieved
maturation to the CD252CD442 and further to the ISP
stage. Because several reports have indicated that Egr-1 ex-
pression is upregulated by irradiation (46) and ras activation
(47, 48), the observation in these transgenic mice is consis-
tent with the previously reported ras-related promotion of
thymocyte development in RAG2/2 mice.
Despite these results which implicate involvement of
Egr-1 in early thymocyte development, Egr-12/2 mice
showed no defect in thymocyte development (49; my un-
published results). Potential compensation for the role of
Egr-1 by other Egr family members, such as Egr-2, -3, and
-4, which are reported to be expressed in the thymus (36),
could explain normal thymocyte development in Egr-12/2
mice. Because the sequence of the zinc finger DNA–bind-
ing site is highly conserved in all members of the Egr family
(29), the set of expressed genes that are required to pro-
mote DN thymocyte development could be induced by
other members of the Egr family, even in the absence of
Egr-1.
Thus, although expression of Egr-1 is not necessary for b
selection, overexpression allows thymocytes to overcome b
selection and mature to the ISP stage.
Two Distinct Steps during Thymocyte Maturation between the
DN and ISP Stages. To our surprise, though thymocytes
overexpressing Egr-1 bypassed the b block and developed
to the ISP stage in a RAG2/2 background, these cells could
not further mature to the DP stage. All other manipulations
reported that induce thymocyte development in RAG2/2
mice drive thymocyte maturation past the b block to the
DP stage. However, irradiation did promote maturation of
DP cells in Egr-1 Tg-RAG2, demonstrating that overex-
pression of Egr-1 itself does not impair thymocyte matura-
tion from the ISP to the DP stage. Thus, transcriptional
regulation by Egr-1 is sufficient to promote maturation of
thymocytes from the CD251CD442 DN to the ISP stage,
but additional regulations that can be induced by irradia-
tion are necessary to drive ISP cells to the DP stage. Several
immediate–early genes other than Egr-1, such as c-jun and
c-fos, are upregulated by irradiation (28, 46). In addition,
p53 expression, which can rescue both the rearrangement
of the TCR-b locus and thymocyte development to the
DP stage in scid mutant mice is also induced by irradiation
(50), though induction of rearrangement is clearly not a
factor in the RAG-22/2 background animals. On the other
hand, null-mutant mice of an high-mobility group box
protein family member, T cell factor 1, revealed a matura-
tion block of thymocytes at the ISP stage, and this protein
appeared indispensable for thymocyte development from
the ISP to the DP stage (51). Though it is not known
whether T cell factor 1 is induced by irradiation, it is a po-
tential candidate as a key player in this developmental pro-
cess. Further studies are required to identify the responsible
gene(s) expression for thymocyte maturation from the ISP
to the DP stage.
One might argue that the signals mediated by TCR-a/b
instead of pre-TCR, might be responsible for the develop-
ment from ISP to DP cells, because the rearrangement of a
chain becomes active and low levels of TCR-a/b expres-
sion can be detected on the cell surface at the ISP stage. It
appears unlikely, however, because thymocytes do develop
to the DP stage even in TCR-a2/2 mice (13).
Overexpression of Egr-1 Might Boost Thymocyte Matura-
tion. The presence of a large population of ISP (and ISP/
DP intermediate) cells in Egr-1 Tg-RAG2 mice after irra-
diation revealed an unexpected effect of Egr-1 overexpres-
sion on immature thymocytes. These cells have the poten-
tial to develop to the DP stage, and it is unlikely that there
is a distinct population that is resistant to induction of mat-
uration by irradiation. In addition, this phenotype was not
due to the hyperproliferation of ISP cells because cell cy-
cling was not affected by overexpression of Egr-1. The
shifted balance of CD251CD442 versus CD252CD442
DN cell populations and increased number of CD42CD8low
cells in irradiated Tg thymi suggest that overexpression of
Egr-1 may boost thymocyte maturation from CD251
CD442 DN to the ISP stages, resulting in an enlarged ISP
population in the thymic profiles. The precise mechanism
of this boost effect by Egr-1 overexpression is unclear.
However, not only CD25 downregulation and CD8 up-
regulation are affected, because these changes were accom-
panied by reduction of cell size and HSA downregulation.
In addition, Egr-1–binding domains have not been identi-
fied either in CD8 or CD25 gene promoter regions. Re-
cently, Eibel and colleagues have generated transgenic mice884 Egr-1–induced Thymocyte Development in RAG-22/2 Mice
which overexpress Egr-1 in B cell lineage under the con-
trol of immunogloblin promoter/enhancer. In these trans-
genic mice, B cell maturation seems to be advanced (Eibel,
H., personal communication). This result appears analogous
with the boosted thymocyte maturation in our transgenic
mice.
Perspective. Newly generated Egr-1 transgenic mice
with a RAG-22/2 background provide several novel in-
sights, two of which are worth reemphasizing. First, over-
expression of Egr-1 is sufficient to promote the develop-
ment of CD251CD442 DN thymocytes to the ISP stage,
beyond b selection. Second, there are two distinct steps
regulating thymocyte maturation between the DN and DP
stages, the turning point of which appears to be at the ISP
stage. Egr-1 transgenic mice may provide a model for fur-
ther dissection of the gene regulation involved in early thy-
mocyte development.
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